Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 23;319(4):337-338.
doi: 10.1001/jama.2017.19138.

Improving Public Health Requires Inclusion of Underrepresented Populations in Research

Affiliations

Improving Public Health Requires Inclusion of Underrepresented Populations in Research

Catherine Y Spong et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Spong and Bianchi are employees of the US federal government and performed this work as part of their official duties.

Figures

Figure.
Figure.. Open NIH-Funded Phase 3 and 4 Studies as of October 19, 2017
Clinicaltrials.gov records (N=338) were reviewed. Exclusion for intellectual disabilities was based on IQ and defined intellectual disability or cognitive impairment; physical disabilities: exclusions for physical disabilities were inability to ambulate, extreme immobility, and paraplegia.

Comment in

References

    1. Cutter GR, Liu Y. Personalized medicine. Neurol Clin Pract. 2012;2(4):343–351. - PMC - PubMed
    1. Brussee JM, Calvier EA, Krekels EH, et al. Children in clinical trials. Expert Rev Clin Pharmacol. 2016;9(9):1235–1244. - PubMed
    1. Andrew MA, Easterling TR, Carr DB, et al. Amoxicillin pharmacokinetics in pregnant women. Clin Pharmacol Ther. 2007;81(4):547–556. - PubMed
    1. Feldman MA, Bosett J, Collet C, Burnham-Riosa P. Where are persons with intellectual disabilities in medical research. J Intellect Disabil Res. 2014;58(9): 800–809. - PubMed
    1. Mestre H, Alkon T, Salazar S, Ibarra A. Spinal cord injury sequelae alter drug pharmacokinetics. Spinal Cord. 2011;49(9):955–960. - PubMed